Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-008918
Filing Date
2025-03-25
Accepted
2025-03-25 17:15:53
Documents
1
Period of Report
2025-03-24

Document Format Files

Seq Description Document Type Size
1 form4-03252025_090350.html 4  
1 form4-03252025_090350.xml 4 3142
  Complete submission text file 0001415889-25-008918.txt   4587
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Issuer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IMMUNOME, INC. 18702 NORTH CREEK PARKWAY, SUITE 100 BOTHELL WA 98011
Business Address
Tsai Philip (Reporting) CIK: 0002026600 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39580 | Film No.: 25769303